Avantor

Kekst CNC is handling the $100M initial public offering of Avantor, supplier of chemicals/services to the biopharma, life sciences and advanced technology sectors. 

Founded in 1904, Avantor merged with NuSil in 2016 and VWR Corp., a $6.4B transaction, in 2017.

Avantor CEO Michael Stubblefield, formerly senior expert for chemicals practice at McKinsey & Co. and VP at Celanese Corp., reported nine-month 2018 revenues of $4.3B and a $33.6M loss.

Kekst CNC’s Daniel Yunger and Liz Cohen handle the IPO. 

Publicis Groupe owns Kekst CNC.